INTRODUCTION
============

The cerebral cortex is formed of two broad classes of neurons: excitatory projection neurons, which primarily use glutamate as a neurotransmitter, and inhibitory GABA-containing interneurons. Whereas projection neurons are generated directly from radial glial cells in the germinal ventricular zone (VZ; reviewed in [@B74] [@B51]) or indirectly from intermediate progenitors in the subventricular zone (SVZ; [@B77], [@B78]), the majority of interneurons are generated in the ventral forebrain and reach the cortex by tangential migration along well-defined streams, guided by a combination of chemoattractive and repulsive cues (reviewed by [@B68]; [@B72]). In rodents, cortical interneurons have been reported to arise predominantly from the medial ganglionic eminences (MGE) or caudal ganglionic eminences (CGE) and, to a smaller extent, from the embryonic preoptic area ([@B53]; [@B76]; [@B107]; [@B36]). They then, display diverse migratory behaviors before establishing themselves in an inside-out manner in the cortical plate (CP), similar to pyramidal neurons ([@B23]; [@B5]; [@B98], [@B99]). In addition, a few studies have suggested that, at least in primates and humans, a significant number of cortical GABAergic neurons may also be generated from progenitors of the VZ and SVZ in the dorsal forebrain ([@B54]; [@B82]; [@B44]; [@B108]). Over the last 15 years, mutant mouse analysis and RNAi-mediated gene knock-down studies have identified several genes encoding transcription factors such as *Dlx1*, *Dlx2*, *Dlx5* (*Distal-less*), *Arx* (*Aristaless-related homeobox*), *Nkx2.1* (*NK2 homeobox 1*), or *Lhx6* (*LIM homeobox protein 6*) important for the correct generation, migration or differentiation of these GABAergic neurons (reviewed by [@B40]).

Over the past decade, numerous studies have demonstrated that a dysfunction of the GABAergic system is responsible for a large variety of neurodevelopmental disorders ([@B8]; [@B55]; [@B25]). In particular, it is now well accepted that there is a connection between altered neuronal positioning, usually due to defects in migration, and susceptibility to epilepsy. Moreover, subtle alterations in interneuron position and/or function have been reported to contribute to disorders such as dyslexia, schizophrenia, autism, and mental retardation ([@B34]; [@B75]). It is thus important to better characterize the molecular mechanisms involved in interneuron generation, migration and differentiation through, for example, the analysis of genes important for interneuron development.

*The ARX* gene was first identified in 2002 as being responsible for a rare and severe cortical malformation in human, the X-linked lissencephaly associated with abnormal genitalia (XLAG), typically characterized by severe congenital or postnatal microcephaly, complete disorganization of cortical layers (lissencephaly), agenesis of the corpus callosum, midbrain malformations, and neonatal-onset intractable epilepsy ([@B49]). Interestingly, a complete absence of interneurons was described in the cortex of these patients ([@B13]; [@B27]; [@B80]; [@B66]). Similarly, aberrant migration and differentiation of GABAergic interneurons in the ganglionic eminences and neocortex were described in male embryonic *Arx* mutant mice ([@B49]; [@B21]). Since then, *ARX* has been associated with no less than 10 different syndromes ranging from phenotypes characterized by severe neuronal migration defects, to mild or moderate forms of intellectual disability without apparent brain abnormalities, but often with dystonia and epilepsy (reviewed in [@B30]; [@B94]).

Although Arx is expressed in several structures including the brain, pancreas, developing testes, heart, skelet al muscle, and liver ([@B11]; [@B20]; [@B12]), the most striking consequences of its loss of function concern the brain and testes in both mouse and human. During development, Arx is expressed early in telencephalic structures, and more specifically in the mantle zones of the developing lateral ganglionic eminences (LGE) and MGE in the basal forebrain. In the developing cortex, its expression is observed in progenitor cells of the VZ as well as in migrating interneurons, but not in radially migrating cells ([@B22]; [@B83]; [@B31]). The extensive cellular co-localization between Arx and GABA in mouse and human brain, as well as the absence of interneurons documented in the cortex of XLAG patients and *Arx* mutant mice have led to propose "interneuronopathy" as a new term to describe the group of pathologies *ARX* is responsible for ([@B46]).

*Arx* encodes a homeobox transcription factor that has been found to contribute to most fundamental processes of brain development: patterning, neuroblast proliferation, neuronal migration and differentiation as well as axonal outgrowth and connectivity ([@B49]; [@B17]; [@B21]; [@B18]; [@B28]), but the signaling pathways controlled by this gene are still unknown. Although two gene expression profile analyses comparing E14.5 wild-type and *Arx* mutant ventral telencephalic tissues have been published in mouse, very few targets for this transcription factor have been described, and only three (*Lmo1*, *Ebf3*, and *Shox2*) were found to be direct ([@B33]; [@B19]). For this reason, we recently performed chromatin immunoprecipitation in Arx-transfected neuroblastoma cells (N2a) or E15.5 mouse embryonic brain, followed by hybridization to mouse promoter arrays (ChIP-chip) in order to identify new direct targets of Arx ([@B85]). We then examined by transcriptomic experiments whether these genes were differently regulated following the ectopic expression of Arx in N2a cells or its knock-down in mouse ventral telencephalon ([@B85]). For the latter, we used the publicly available microarray data generated by [@B33] and [@B19], comparing gene expression between basal telencephalon of E14.5 *Arx* knock-out and wild-type mice. Out of a total of 1006 genes which promoters were found to be enriched in Arx-immunoprecipitates, approximately 24% showed expression changes following Arx overexpression or knock-down ([@B85]).

In order to provide novel insights into genetic networks regulated by Arx and specifically controlling the development of GABAergic neurons, we took advantage of previously published studies comparing the level of expression of genes between, on one hand, cortical interneurons (*Dlx5/6*-derived cells) and cortical non-interneurons (non-*Dlx5/6*-derived cells) in the telencephalon of E13.5, E14.5, and E15.5 mice ([@B7]; [@B70]) and, on the other hand, genes expressed by GABAergic neurons (*Gad67*-positive cells) in the ganglionic eminence versus those migrating in the cortex at the same stages ([@B70]; [@B26]). As Arx is strongly expressed in cortical migrating interneurons, we decided to compare these datasets with ours and present here a list of ChIP-positive (Arx-bound) and regulated genes ([@B85]) that are enriched or down-regulated in migrating cortical interneurons and, thus, are good candidates to control, positively or negatively, molecular mechanisms involved in interneuron migration and/or differentiation (**Table [1](#T1){ref-type="table"}**).

###### 

List of candidate genes regulated by Arx and controlling cortical interneuron migration and/or differentiation

  Gene symbol   Gene name                                                      Human CNS disease                                      Mouse endophenotype
  ------------- -------------------------------------------------------------- ------------------------------------------------------ -----------------------------------------------------
  *Cxcr 7*      Chemokine (C-X-C motif) receptor 7                             NA                                                     Interneuron migration defects
  *Meis1*       Meis homeobox 1                                                Restless legs syndrome                                 NA
  *Ppap2a*      Phosphatidic acid phosphatase type 2A                          NA                                                     NA
  *Slc12a5*     Solute carrier family 12, member 5                             NA                                                     Severe motor deficits
  *Ets2*        E26 avian leukemia oncogene 2                                  May contribute to Down syndrome                        NA
  *Phlda1*      Pleckstrin homology-like domain, family A, member 1            NA                                                     NA
  *Egr1*        Early growth response 1                                        NA                                                     Learning and memory defects
  *Igf1*        Insulin-like growth factor 1                                   Growth retardation, deafness, and mental retardation   Defects in neurologic development
  *Lmo3*        LIM domain only 3                                              NA                                                     NA
  *Sema6a*      Semaphorin 6A                                                  NA                                                     Impaired development of thalamocortical projections
  *Lgi1*        Leucine-rich repeat LGI family, member 1                       Lateral temporal epilepsy                              Increased excitatory synaptic transmission
  *Alk*         Anaplastic lymphoma kinase                                     Susceptibility to neuroblastoma                        NA
  *Tgfb3*       Transforming growth factor, beta 3                             NA                                                     NA
  *Napb*        *N*-ethylmaleimide-sensitive factor attachment protein, beta   NA                                                     NA
  *Hmgn3*       High mobility group nucleosomal binding domain 3               NA                                                     NA
  *Lmo1*        LIM domain only 1                                              NA                                                     NA
  *Ebf3*        Early B-cell factor 3                                          NA                                                     Interneuron migration defects
  *Rasgef1b*    RasGEF domain family, member 1B                                Candidate for the 4q21 deletion syndrome               NA
  *Slit2*       Slit homolog 2 (*Drosophila*)                                  NA                                                     Abnormal axonal projections

NA, not available

.

IDENTIFICATION OF CANDIDATE GENES POSITIVELY REGULATING CORTICAL INTERNEURON MIGRATION AND/OR DIFFERENTIATION
=============================================================================================================

As shown in **Table [2](#T2){ref-type="table"}**, we identified 14 ChIP-positive genes (genes whose promoters were enriched in Arx-immunoprecipitates) that showed deregulation, either following Arx overexpression in N2a cells or in *Arx* mutant subpallium ([@B85]), and appeared enriched in migrating cortical interneurons ([@B7]; [@B70]; [@B26]). Thus, these genes are good candidates to positively control molecular mechanisms involved in cortical interneuron migration and/or differentiation.

###### 

Examples of Arx-bound and regulated genes that are enriched in migrating cortical interneurons (IN) compared to neurons in ganglionic eminences (GE) and cortical non-interneurons (non-IN).

  Gene                 Arx knock-out mice                                       Arx-transfected N2a cells    Expression in cortical migrating interneurons               
  -------------------- -------------------------------------------------------- ---------------------------- ----------------------------------------------- ----------- ---------------
  *Cxcr7*              ↓ KO subpallium (FC = 1.6, *p* \< 0.05/[@B19])           No specific change           IN \> GE at E13.5 and E15.5                     2.2--2.3    [@B26]
  *Meis1*              No specific change                                       ↑ N2a cells (\< 0.005)       GE \> IN at E13.5 and E15.5                     2.6--2.8    [@B26]
                                                                                                             IN \> non-IN at E13.5                           2.6         [@B7]
  *Ppap2a*             ↑ KO subpallium (FC = 1.4, *p* \< 0.05)                  ↑ N2a cells (*p* \< 0.05)    IN \> non-IN at E13.5                           2.2         [@B7]
  *Slc12a5* = *KCC2*   ↑ KO subpallium (FC = 1.8, *p* \< 0.005)                 ↑ N2a cells (*p* \< 0.05)    IN \> non-IN at E13.5 and E15.5                 7.7         [@B7]
  *Ets2*               ↑ KO subpallium (FC = 1.8, *p* \< 0.001)                 ↑ N2a cells (*p* \< 0.005)   IN \> non-IN at E13.5                           2.7         [@B7]
  *Phlda1*             ↑ KO subpallium (FC = 2.2, *p* \< 0.05/[@B33])           ↑ N2a cells (*p* \< 0.01)    IN \> non-IN at E13.5 and E15.5                 3.2-3.7     [@B7]
                                                                                                             IN \> non-IN at E14.5                           NA          [@B33]
  *Zif268* = *Egr1*    ↑ KO subpallium (FC = 3.1, *p* \< 0.05)                  No specific change           IN \> GE at E13.5 and E15.5                     1.9--2.5    [@B26]
                                                                                                             IN \> non-IN at E13.5                           6.4         [@B7]
  *Igf1*               ↑ KO subpallium (FC = 1.5-5, *p* \< 0.001)               No specific change           IN \> non-IN at E15.5                           6.9         [@B7]
  *Lmo3*               ↑ KO subpallium (FC = 3.3, *p* \< 0.001/[@B33]/[@B19])   No specific change           IN \> non-IN at E14.5                           6.9         [@B33]
  *SemaGa*             ↑ KO subpallium (FC = 1.6, *p* \< 0.01)                  No specific change           IN \> GE at E15.5                               1.9         [@B26]
  *Lgi1*               No specific change                                       ↓ N2a cells (*p* \< 0.005)   IN \> non-IN at E13.5 and E15.5                 2.7--26.2   [@B7]/ [@B70]
  *Alk*                No specific change                                       ↓ N2a cells (*p* \< 0.05)    IN \> GE at E13.5 and E15.5                     1.8--2.2    [@B26]
                                                                                                             IN \> non-IN at E13.5 and E14.5                 2.5         [@B7]/ [@B70]
  *Tgfb3*              No specific change                                       ↓ N2a cells (*p* \< 0.005)   IN \> GE at E13.5 and E15.5                     3.4--4.5    [@B26]
                                                                                                             IN \> non-IN at E13.5 and E15.5                 5.3-5.5     [@B7]
  *Napb*               No specific change                                       ↓ N2a cells (*p* \< 0.05)    IN \> GE at E15.5                               2           [@B26]
                                                                                                             IN \> non-IN at E13.5                           2.6-3       [@B7]

FC, fold change; NA, not available.

*In vitro* and *in vivo* studies have previously demonstrated that Arx can act as both transcriptional repressor and activator ([@B91]; [@B71]; [@B32]). Accordingly, eight of Arx putative direct targets presented in **Table [2](#T2){ref-type="table"}** (*Egr1*, *Igf1*, *Lmo3*, *Sema6a*, *Lgi1*, *Alk*, *Tgfb3*, and *Napb*) show either a significant reduction in expression as a consequence of increased Arx levels or increased expression in *Arx* knock-out brains (**Table [2](#T2){ref-type="table"}**). However, four genes (*Ppap2a*, *Slc12a5*, *Ets2*, and *Phlda1*) show similar changes in expression following Arx overexpression or knock-down, thus making it difficult to determine whether Arx normally activates or represses these genes in migrating interneurons. We had previously described similar results for some other genes and suggested that Arx may switch from repressor to activator depending on the developmental stage, the molecular context (posttranslational modifications such as phosphorylation or the presence of cofactors and/or chromatin-modifying enzymes) or the cellular model used ([@B85]). On the contrary, two genes look positively regulated by Arx (**Table [2](#T2){ref-type="table"}**).

One such gene positively regulated by Arx is *Cxcr7* (*CXC chemokine receptor 7*), which role in interneuron migration has recently been described ([@B90]; [@B102]). Cxcr4 and Cxcr7 are receptors for the chemokine Cxcl12 (also called Sdf1, stromal cell-derived factor) expressed in tangentially migrating interneurons ([@B90]; [@B102]). Cxcl12 binding to Cxcr4 triggers G*α*I protein-dependent signaling, whereas Cxcl12 binding to Cxcr7 activates the mitogen-activated protein kinase (MAPK) cascade ([@B102]). Cxcl12 expression in the marginal zone (MZ) and SVZ of the cortex attracts Cxcr4- and Cxcr7-expressing migrating interneurons, guiding them to tangential streams and controls the timing of the switch from tangential to radial migration to their destinations in the CP ([@B100]; [@B56]; [@B62]; [@B102]). Loss of Cxcl12 signaling has been shown to induce defects in both interneuron motility and leading process morphology, as well as a premature entry into the CP, resulting in a significant decrease in their numbers in the migratory streams and an increase in the lower part of the CP ([@B97]; [@B100]; [@B56]; [@B57]; [@B62]; [@B64]; [@B90]; [@B102]).

Interestingly, *Cxcr7* mRNA has been shown to be down-regulated in cortical interneurons and the GE of *Dlx1/2* knock-out mice ([@B59],[@B60]). Similarly, Cxcr7 and Cxcr4 receptors are positively regulated by Lhx6 ([@B109]). *Dlx1*, *Dlx2*, and *Lhx6* have all been shown to be important for tangential interneuron migration ([@B3]; [@B2]; [@B58]). Similarly, we found in previous work that Arx binds *Cxcr7* promoter ([@B85]) and positively regulates its expression which, in turn, regulates Cxcr4 protein levels ([@B90]). Accordingly, Cxcr4 expression was found down-regulated in *Arx* mutant subpallium ([@B33]; [@B19]). As *Arx* expression was shown to be regulated by several members of the *Dlx* family of homeobox proteins, particularly *Dlx2* ([@B17]), we may hypothesize that interneuron migration defects observed in *Dlx1/2*, *Lhx6*, or *Arx* mutants are, at least in part, due to abnormal Cxcl12 signaling pathway. In addition, *Cxcr4^-/-^* and *Cxcr7^-/-^* mutants have been reported to have defects in leading process morphology during migration ([@B102]), which may also be related to the cell morphology defects observed in migrating inter-neurons in the absence of *Arx* ([@B21]; [@B28]).

Another gene enriched in cortical migrating interneurons and positively regulated by Arx is *Meis1* (*murine ecotropic integration site 1*), a transcription factor involved in cell proliferation in retina and hematopoietic stem cell development. Although the function of this gene has not been studied in interneurons, its expression is consistent with a role in GABAergic neuron development. First detected around E10.5 in mouse ventrolateral telencephalon, it is expressed at later stages at high levels in the CGE and developing amygdala and more weakly in the MGE and LGE ([@B101]). Interestingly, a recent paper on the effect of *Meis1* knock-down in a human precursor B-cell leukemic line RS4;11 reported an impairment of cell migration, possibly due to a defect in the CXCR4/SDF-1 axis ([@B81]). Further studies should be undertaken in interneurons to assess whether this gene is also important for their migration and/or differentiation. This may be a worthwhile pursuit, as this gene has been linked to the restless legs syndrome (RLS), a common neurological disorder characterized by an irresistible urge to move the legs at night. RLS is generally considered to be a central nervous system-related disorder due to reduced intracortical inhibition and is often treated by benzodiazepines, a class of sedative drugs affecting the GABA receptors.

Among the genes that appear negatively regulated by Arx is *Egr1* (*early growth response 1*), a transcription factor that has been implicated in synaptic plasticity underlying learning and memory in mouse ([@B16]). A recent study has reported that Egr1 overexpression in rat brain hippocampus and primary cultures of neurons regulates cytoskeleton dynamics by inactivating the phosphatase PP1 and activates cyclin-dependent kinase 5 (Cdk5) to promote phosphorylation of Tau, a microtubule-associated protein ([@B63]). This is of particular interest, as both Cdk5 and PP1 are involved in neuronal migration ([@B37]; [@B93]; [@B86]). The observed enrichment of this gene in cortical migrating interneurons suggests that it may positively control interneuron migration and/or differentiation. Accordingly, angiopoietin-1 (Ang-1) was found to stimulate cell migration in endothelial cells by increasing expression of Egr1 ([@B1]). In addition, it has been reported that Reelin, produced by the mitral cells of the olfactory bulb (OB), activates the MAPK/extracellular signal-regulated kinase (ERK) pathway and induces Egr-1 transcription, which in turn promotes the shift from tangential/chain to radial/individual neuronal migration, and the detachment of neurons in the rostral migratory stream (RMS; [@B95]). These findings are particularly relevant as Reelin, produced by Cajal--Retzius cells, is also important for neuronal migration in the cortex. It is thus possible that fine regulation of Egr1 expression may be necessary to control cortical interneuron migration and the switch from tangential to radial mode into the CP.

Interestingly, *Egr1* expression was found up-regulated in *Arx* mutant mice (**Table [2](#T2){ref-type="table"}**), suggesting that Arx normally represses its expression inthe subpallium. Thisissomewhat contradictorywith its putative positive role in cell migration. This discrepancy may be explained by the fact that Arx is expressed in different cell types in the forebrain during development (cortical neuronal progenitors, subpallial postmitotic cells, and cortical migrating interneurons) and may thus differentially regulate the same gene depending on the developmental stage, the biological context or the molecular environment. It is thus possible that Arx normally down-regulates *Egr1* in the subpallium in order to keep these cells undifferentiated, but up-regulates it in cortical migrating interneurons. Alternatively, *Egr1* up-regulation in *Arx* mutant mice may just be the result of the accumulation of cells that failed to exit the subpallium in the absence of *Arx*.

Another gene that may have a similar role is *Igf1* (*Insulin-like growth factor-1*), which encodes a growth factor highly expressed in embryonic brain. It has been implicated in several processes such as projection neuron growth, dendritic arborization, synaptogenesis, and adult hippocampal neurogenesis. In human, mutations in this gene are responsible for intrauterine and postnatal growth retardation with sensorineural deafness and intellectual deficit ([@B105]). In mouse, disruption of *Igf1* results in reduced brain size, hypomyelination, and loss of hippocampal granule and striatal parvalbumin-containing neurons ([@B9]). More recently, this gene was found to promote neuronal migration and positioning in the OB and the incorporation of neuroblasts from the SVZ to the RMS ([@B42]). *Igf1^-/-^* mice display altered pattern of OB layering with, in particular, a misplacement of glutamatergic neurons in the mitral cell layer (ML) and the external plexiform layer (EPL), a depletion of several populations of interneurons in the glomerular layer and the EPL, and an accumulation of neuroblasts in the postnatal and adult SVZ ([@B42]). Interestingly, these authors observed that a number of misplaced glutamatergic neurons in the ML had failed to radially re-orient their cell bodies, maintaining a relatively tangential orientation. These results suggest that, in the absence of *Igf1*, there was a defect in the switch from tangential to radial migration in the ML of the OB ([@B42]). In addition, they showed that Dab1 activity was necessary for Igf1 action suggesting that, similar to Egr1, its role in interneuron migration may, at least partly, intersect with the Reelin signaling pathway ([@B42]). Finally, a role for Igf1 has also been demonstrated in the GABAergic differentiation of neural precursors through the activation of the Pdk1/Akt pathway, which induces *Mash1* expression ([@B79]). The fact that *Pdk1* was found repressed in Arx-overexpressing N2a cells ([@B85]) confirms the involvement of Arx in this pathway and may explain the reason why some GABAergic neurons, and especially NPY^+^ and ChAT^+^populations, were found strongly reduced in *Arx* mutant forebrains ([@B49], [@B48]; [@B21]; [@B84]).

Similar to *Egr1* and *Igf1*, *Arx* knock-out mice display increased expression of the *Sema6a* (*semaphorin 6a*) gene in the subpallium (**Table [2](#T2){ref-type="table"}**). Like other semaphorins, Sema6a is better known for its function in thalamocortical axon guidance, but it has also been reported to play a role in cell migration during cerebellum development. This protein is selectively expressed by postmitotic granule cells during their tangential migration in the deep external granule cell layer, but not during their radial migration ([@B47]). The analysis of granule cell migration and neurite outgrowth in cerebellar explants of mutant mice for *Sema6a*, or for its receptor *Plexin a2*, revealed that Sema6a controls the switch from tangential to radial migration by regulating centrosome--nucleus coupling and cellular translocation ([@B47]; [@B87]). The role of Sema6a in cortical interneuron migration has never been studied, but this gene is probably a good candidate as other members of the semaphorin family have been shown to be important for the guidance of cortical interneurons as they migrate in the ventral telencephalon ([@B69]; [@B39]).

Although no change of *Lgi1* (*leucine-rich*, *glioma-inactivated*) was detected in *Arx* mutant subpallium, this gene was found to be down-regulated following *Arx* transfection in N2a cells. Interestingly, mutations of this gene result in autosomal dominant lateral temporal epilepsy ([@B45]). Enhanced excitatory synaptic transmission through increased release of glutamate has been suggested as a basis for the seizure phenotype. *Lgi1*, which encodes a secreted protein involved in postnatal glutamatergic synapse development, has not been studied in interneurons, but its strong enrichment in these cells compared to cortical non-interneurons (**Table [2](#T2){ref-type="table"}**, fold change = 26.2 at E13.5), suggests an important role in interneuron development and possibly migration, as Lgi1 has been shown to regulate cell mobility through the formation of stress fibers in glioblastoma cells ([@B52]).

At the start of corticogenesis, GABAergic interneurons enter the neocortex at the level of the preplate layer (PPL) and IZ. Loss of the upper stream(s) was reported at E14.5 and E18.5 in *Arx* knock-out mice, but the stream in the IZ/SVZ looked intact ([@B49]; [@B21]). Interestingly, *Lgi1* has recently been found up-regulated in cortical migrating interneurons of the PPL compared to the IZ layer at E14.5 ([@B6]). It is thus possible that regulation of *Lgi1* expression by Arx may explain the loss of the PPL migratory stream, but not the IZ stream in *Arx* mutant cortex ([@B49]).

*Tgfb3* (*transforming growth factor, beta 3*) encodes a member of the TGF-β family of proteins. They act by stimulating specific membrane serine/threonine receptor complexes resulting in the phosphorylation and activation of Smad transcription factors (regulatory Smad, R-smad). Smad1, Smad5, and Smad8 are mainly activated by bone morphogenetic protein (BMP) and growth differentiation protein (GDF) receptors, while Smad2 and Smad3 are substrates for TGF-β, activin, and Nodal receptors. Once activated, the R-Smads accumulate in the nucleus where they associate with Smad4, a common partner for all R-Smads to form transcription complexes. Interestingly, in addition to *Tgfb3*, we found that Arx binds to *Smad1* and *Smad4* regulatory sequences in both neuroblastoma cells and E15.5 mouse embryonic brain, and that Arx overexpression in N2a cells results in *Smad1* down-regulation ([@B85]), confirming a possible involvement of Arx in the TGF-β signaling pathway. [@B65] have recently investigated a possible role for the TGF-β superfamily pathway in telencephalic GABAergic neuron development. They first showed that *Smad1*, *Smad2*, *Smad4*, and *Smad5* are expressed in the sub-pallium at E15.5, where they exhibit expression levels similar to those of *Dlx* genes. They also observed the presence of activated Smad1 and Smad2 in the developing basal ganglia and in cortical migrating interneurons. In addition, inhibition of TGF-β signaling by the use of dominant-negative forms of Smad proteins in the basal ganglia, impairs tangential migration of cortical interneurons: Smad1 or Smad2 dominant negative mutants only partially blocked migration, whereas inhibition of Smad4 completely abrogated the migration of electroporated cells to the cortex, thus providing evidence that both branches of the TGF-β signaling pathway are important for cortical interneuron migration ([@B65]).

It is interesting to note that Arx transfection of N2a cells induces down-regulation of *Smad1*, but that the level of expression of *Smad1* and *Smad4* was unchanged in *Arx* knock-out, similar to *Dlx1/2* mutant mice ([@B65]). It had thus been suggested that expression of most TGF-β superfamily genes was not downstream of Dlx. Interestingly, we found that Arx up-regulates two more components of the TGF-β superfamily, *Smad3* and *Bmper* (BMP binding endothelial regulator). The latter was recently identified as a Dlx5 direct target in inner ear ([@B88]). As *Arx* expression is ectopically induced by forced expression of *Dlx1*, *Dlx2*, or *Dlx5* in mouse dorsal thalamus ([@B17]), it appears very likely that the Dlx and Arx genes act through the same components of the TGF-β pathway to regulate interneuron migration and/or differentiation.

The *Slc12a5* gene (*solute carrier family 12*, *member 5*, also called *KCC2*, *potassium/chloride cotransporter 2*) was found up-regulated in both *Arx* mutant subpallium and transfected N2a cells, confirming that it is a direct target of Arx. Up-regulation of Slc12a5 by migrating interneurons results in the termination of their tangential migration and allows the radial sorting of different populations of tangentially migrating interneurons, resulting in their layer-specific integration into the emerging cortical network ([@B15]; [@B73]). It is thus likely that Arx, through *Slc12a5* expression, regulates the timing of migration and the final organization of interneurons in cortical layers.

There is little information available concerning the other genes found enriched in migrating cortical interneurons. As *Slc12a5*, the *Phlda1* (*pleckstrin homology-like domain, family A, member 1*) gene was found up-regulated in both *Arx* mutant subpallium and transfected N2a cells (**Table [2](#T2){ref-type="table"}**). This gene encodes a proline--histidine rich nuclear protein which is specifically induced by Igf1. Although it has never been studied in interneuron development, it has recently been reported that siRNA-mediated suppression of *Phlda1* in colon cancer cells inhibited cell migration ([@B89]). Similarly, *Ppap2a* (*phosphatidic acid phosphatase type 2A*) encodes an enzyme that converts phospha-tidic acid to diacylglycerol and functions in *de novo* synthesis of glycerolipids. Ppap2a has been shown to reduce platelet-derived growth factor (PDGF)- and lysophosphatidic acid-induced migration of embryonic fibroblasts ([@B61]). Concerning Ets2 (*E26 avian leukemia oncogene 2*), this gene encodes a transcription factor located on chromosome 21 which has been suggested to contribute to Down syndrome's phenotype. Its role is not yet well understood. Finally, the *Lmo3* (*LIM-only protein 3*) gene was consistently found up-regulated in *Arx* mutant subpallium ([@B18]; [@B33]; this study). Forced expression of this gene in the MGE of E14.5 brain slices has no effect on neuronal migration ([@B19]), suggesting that Lmo3 expression is not required for the initiation of migration. However, to exclude a definite role in migration, it would be interesting to knock down this gene specifically during migration. In addition, Lmo3 has been reported to form a complex with HEN2 and induce *Mash1* expression ([@B43]). Although these observations were made in neuroblastoma cells, this is potentially relevant as *Mash1* is known to be specifically expressed in the ventral part of the telencephalon and contributes to the generation of GABAergic neurons.

In contrast, the *Alk* (*Anaplastic lymphoma kinase*) gene seems to be repressed by Arx. This gene encodes a receptor tyrosine kinase (RTK) that has been shown to concentrate in postsynaptic domains. Its role in interneuron development has never been studied. Similarly, *Napb* encodes soluble *N*-ethylmaleimide-sensitive factor (NSF) attachment protein beta (beta Snap) involved in SNAP receptor (SNARE)-mediated vesicle trafficking and synapse formation. The mode of migration used by cortical interneurons is very similar to that of other types of migrating cells. They first extend a leading process in the direction of migration, followed by nuclear translocation and the retraction of the trailing process ([@B72]). During migration, interneurons show highly dynamic branching with changes in the orientation of the leading process, migration in all directions within streams and the use of different substrates. The role of vesicular trafficking in processes such as endocytosis to regulate substrate attachment or detachment, or membrane cycling from the leading and trailing process is thus very important ([@B96]; [@B92]).

IDENTIFICATION OF CANDIDATE GENES NEGATIVELY REGULATING CORTICAL INTERNEURON MIGRATION AND/OR DIFFERENTIATION
=============================================================================================================

We found five Arx-bound genes specifically down-regulated in migrating cortical interneurons compared to neurons of the GE or cortical non-interneurons (**Table [3](#T3){ref-type="table"}**). Thus, these genes may be necessary for cortical progenitor proliferation and/or pyramidal neuron development. Alternatively, as Arx negatively regulates most of these genes, they may repress interneuron migration and/or differentiation.

###### 

Examples of Arx-bound and regulated genes that are down-regulated in migrating cortical interneurons (IN) compared to neurons in the ganglionic eminences (GE) and cortical non-interneurons (non-IN).

  Gene         Arx knock-out mice ([@B85])                              Arx-transfected N2a cells   Expression in cortical migrating interneurons              
  ------------ -------------------------------------------------------- --------------------------- ----------------------------------------------- ---------- ---------------
  *Hmgn3*      ↓ KO subpallium (FC = 1.3, *p* \< 0.001)                 No specific change          GE \>IN at E15.5                                2.1        [@B26]
                                                                                                    Non-IN \> IN at E13.5                           2.6-2.9    [@B7]
  *Lmo1*       ↑ KO subpallium (FC = 1.6, *p* \< 0.001/                 ↓ N2a cells (*p* \< 0.05)   GE \> IN at E13.5 and E15.5                     3.0--5.3   [@B26]
               [@B33]/[@B19])                                                                       Non-IN \> IN at E13.5 and E15.5                 3.3-5.6    [@B7]/ [@B33]
  *Ebf3*       ↓ KO subpallium (FC = 1.6, *p* \< 0.001/[@B33]/[@B19])   No specific change          GE \> IN at E13.5 and E15.5                     2.0--2.3   [@B26]
                                                                                                    Non-IN \> IN at E13.5                           5.5        [@B7]/[@B33]
  *Rasgef1b*   ↑ KO subpallium ([@B33]/[@B19])                          No specific change          GE \> IN at E13.5                               3          [@B26]
                                                                                                    Non-IN \> IN at E14.5                           NA         [@B33]
  *Slit2*      ↑ KO subpallium (FC = 1.4, *p* \< 0.005)                 No specific change          GE \> IN at E13.5 and E15.5                     2.1--2.2   [@B26]
                                                                                                    Non-IN \> IN at E13.5                           3.5        [@B7]

FC, fold change; NA, not available.

Only one gene, *Hmgn3* (*high mobility group nucleosomal binding domain 3*) appears to be positively regulated by Arx (**Table [3](#T3){ref-type="table"}**). This gene encodes a nucleosome binding protein that affects chromatin function. It has been reported to induce the expression of the glycine transporter 1 gene (Glyt1), a membrane transporter that regulates glycine concentration in synaptic junctions ([@B104]). In addition, Hmgn3 expression is very similar to that of the glial fibrillary acidic protein (GFAP), suggesting that it might play a role in astrocyte function.

The four other genes seem to be repressed by Arx (**Table [3](#T3){ref-type="table"}**) and may thus normally inhibit cortical interneuron migration and/or differentiation. Accordingly, a recent study has shown that ectopic expression of one of these genes, *Ebf3* (*early B-cell factor 3*), in basal ganglia severely interferes with tangential migration of GABAergic interneurons to the cortex. On the opposite, knock-down experiments targeting this gene in *Arx* mutant mice were found to rescue, at least partially, neuronal migration defects ([@B19]). These results confirm the implication of this transcription factor in neuronal migration, although the underlying mechanisms are still unknown. Ebf3 is also known to be expressed in the developing hindbrain and spinal cord where it promotes neuronal differentiation and radial migration ([@B35]). This gene is normally not (or only marginally) expressed in the developing telencephalon, but it was found strongly misexpressed in the MGE and present in the LGE of *Arx* mutant mice ([@B19]). Interestingly, it was also found up-regulated in *Dlx1/2* mutant subpallium ([@B33]), suggesting that Ebf3 may belong to a pathway that is common to *Dlx* and *Arx* genes ([@B17]).

The *Rasgef1b*(*RasGEF domain family, member 1b*) gene encodes a guanine nucleotide exchange factor (GEF) for Ras family proteins, and several members have been reported as key regulators of actin and microtubule dynamics during dendrite or spine structural plasticity. GEF proteins stimulate the intrinsic GDP/GTP exchange activity of Ras and promote the formation of active Ras-GTP, which in turn controls diverse signaling networks important for the regulation of cell proliferation, survival, differentiation, vesicular trafficking, or gene expression. Rasgef1b has been shown to function as a very specific exchange factor for Rap2, which is implicated in the regulation of cell adhesion, the establishment of cell morphology, and the modulation of synapses in neurons ([@B106]). Normally located in the differentiated striatal mantle, *Rasgef1b* was found misexpressed in the SVZ of the basal ganglia of *Arx* mutant mice ([@B19]). Interestingly, it is present in some migrating cortical interneurons, at least in the IZ layer, compared to the PPL ([@B6]) suggesting that, contrary to *Ebf3*, the expression of this gene is compatible with migration. In addition, whereas it was found up-regulated in *Arx* mutant subpallium, it appeared down-regulated in *Dlx1/2* mutants ([@B33]), suggesting that the role of this gene in neuronal migration may be more complex than just the control of cell motility. However, since this gene has been linked to severe mental retardation, absent speech, distinctive facial features, and severe growth delay ([@B14]), the study of this gene is probably worth pursuing.

Similarly, *Lmo1* (*LIM domain only 1*) gene, consistently found repressed by Arx in several previous studies ([@B33]; [@B19]; [@B85]), is found down-regulated in migrating cortical interneurons (**Table [3](#T3){ref-type="table"}**). Interestingly, we found that Arx also regulates other members of this family of LIM-containing transcription factors. Arx directly binds to *Lmo3* and *Lmo4* promoters and down-regulates their expression in N2a-transfected cells as shown by gene expression profile analysis and quantitative RT-PCR ([@B85] and data not shown). Accordingly, *Lmo1*, *Lmo3*, and *Lmo4* genes were found up-regulated in *Arx* mutant subpallium ([@B33]; [@B19]). These three genes are normally never, or only marginally, transcribed in the ventral telencephalon, but were found strongly expressed in *Arx* mutant MGE and LGE/CGE ([@B19]). It is thus possible that they play important roles in interneuron differentiation.

The last gene found to be down-regulated in migrating cortical interneurons is *Slit 2* (*slit homolog 2*, *Drosophila*). This chemorepulsive ligand and its receptors of the Robo family are expressed in the developing and adult brain and have been reported to regulate commissural axon guidance and axonal branching as well as cell migration. Double labeling experiments have shown that the vast majority of cortical interneurons express Robo1 and Robo2 and that Slit proteins are present in a complementary manner in the proliferative zones of the ventral telencephalon and in the septum during early and mid-phases of corticogenesis ([@B4]). Evidence from *in vitro* experiments indicates that migration of Robo-expressing interneurons is initiated by the chemorepulsive activity of Slit secreted from the VZ of the LGE. In the developing cortex, Slit1 is robustly expressed in the CP, Slit3 is restricted to the MZ, while Slit2 is weakly expressed in the VZ. The presence of a putative Slit gradient along the interneuron migratory routes suggests that Slit/Robo signaling may also play a role in the positioning of the different tangential migratory paths within the developing cortex. However, it has been reported that migration of cortical interneurons is normal in *Slit1/Slit2* double knock-out mice, prompting speculation that Slits do not play a major role in tangential migration, although they seem to be important regulators of neuronal positioning within the basal telencephalon ([@B67]). Nevertheless, the Slit/Robo signaling pathway has also been shown to regulate cell division and interneuron morphology ([@B4]).

CONCLUSION
==========

The *Arx* gene has been shown to play different roles in brain development: patterning, cell proliferation, migration and differentiation as well as axonal outgrowth and connectivity ([@B49]; [@B17]; [@B21]; [@B18]; [@B28]). Accordingly, we recently identified a high number of putative direct targets for this transcription factor ([@B85]), several of them being involved in cell proliferation, cytoskeleton dynamic regulation, axonal guidance, or neurotransmission. To narrow the analysis of Arx targets to those most likely to control cortical interneu-ron migration, we compared our data to previously published studies in search of genes enriched or down-regulated in cortical migrating interneurons. We found several Arx-bound and regulated genes that may be good candidates to explain the severe defects of interneuron migration observed in the absence of *Arx* in both human and mice. In particular, we identified a few genes (*Igf1*, *Egr1*, *Cxcr7*, *Sema6a*, and *Slc12a5*) involved in the control of the mode of migration or the switch from tangential to radial migration. This is of particular interest in the light of our previous observation, that Arx overexpression in radially migrating cells promotes tangentially orientated migration in the SVZ and lower IZ, although these cells do not express GABAergic markers ([@B28]; [@B30]).

As previously reported ([@B70]), several of the genes that were enriched in migrating cortical interneurons are involved in synaptic transmission (*Egr1*, *Igf1*, *Lgi1*, *Alk*, *Napb*, *Glyt1*,...), probably due to the fact that migration is known to be partly controlled by paracrine transmitter release requiring synaptic vesicle proteins. One of these genes, Slc12a5, has been identified as a direct target for Arx ([@B85]), thus implicating Arx in the control of the capacity for migrating cells to respond to GABA and switch from depolarization to hyperpolarization ([@B10]), resulting in a voltage-sensitive, calcium-mediated reduction of interneuron motility. Interestingly, we identified several putative direct targets for Arx which are related to calcium release (*Caln1*, *Calu*, *Cacng4*, *Camkv*, *Cacna2d1*, the latter being specifically down-regulated in cortical migrating interneurons) that may be good candidates for a role during interneuron migration.

It is not always clear whether the genes we identified are normally activated or repressed by Arx as a few genes in **Tables [2](#T2){ref-type="table"} and [3](#T3){ref-type="table"}** showed the same the type of regulation in Arx-overexpressing N2a cells and in knock-out brains. These apparent discrepancies may have several explanations. First, it is important to note that the microarray experiments on Arx knock-out brains were performed from ventral telencephalon ([@B33]; [@B19]), thus leaving out possibly different gene expression changes during interneuron migration and differentiation in the cortex. Second, some changes in gene expression may be too low to be detected in microarray experiments. We previously observed that some Arx-bound genes such as *Gabrb3*, *Lmo3*, or *Cdh2* showed a change of expression in qRT-PCR experiments following Arx expression in N2a cells but not on microarrays ([@B85]). Third, Arx is expressed in different cell types during brain development and in adult, and it is thus possible that, depending on the presence or the absence of specific cofactors it may activate one gene at some stage and repress the same gene at a different time or in a different cell. Fourth, changes or the absence of change in a given gene expression may be the result of some compensatory effect of *Arx* knock-out or overexpression.

In addition, the disadvantage of using transfected N2a cells is that, as *Arx* is normally not expressed in these cells, it may lack binding partners and/or cofactors necessary to regulate the expression of certain genes. On the other hand, as we performed gene expression analysis relatively shortly (2 days) after Arx transfection in N2a cells, it is likely that the changes we see are a direct effect of *Arx* expression. For example, important genes for cortical development such as *Dab1* or *Dclk1* were found repressed following Arx transfection in N2a cells ([@B85]). Dab1 is an intracellular adaptor which is expressed in cells that respond to Reelin and is required for correct radial migration of cortical pyramidal neurons ([@B41]; [@B103]). Expression of *Dab1* in early-born interneurons has also been shown to be required for correct cortical layering ([@B38]). Similarly, *Dclk1* (doublecortin-like kinase 1) is necessary for correct migration of both pyramidal cells and interneurons ([@B24]; [@B50]; [@B29]). Thus, gene expression in transfected N2a cells brings new and complementary information to expression studies performed in *Arx* mutant subpallium ([@B33]; [@B19]).

In conclusion, we identified here a set of candidate genes important for cortical interneuron migration and/or differentiation. Some of these genes have already been described to play a role in neuronal migration, but others have never been investigated in this context. Further studies will definitely bring new information about their function and how their possible regulation byArx may lead to the dysfunction of GABAergic neurons, resulting in mental retardation and epilepsy.
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